Effects of sodium-glucose co-transporter inhibitors on individual clinical endpoints and quality of life.
Liao J, Chen Y, Ling Z, Pürerfellner H, Martinek M, Derndorfer M, Niel J, Ebrahimi R, Heukäufer M, Janschel S, Di Vece D, Empen K, Hummel A, Chamling B, Futyma P, Ebrahimi F, Kiuchi MG, Liu S, Yin Y, Schratter A, Acou WJ, Sommer P, Schmidt B, Chun JKR, Meyer C, Dörr M, Templin C, Chen S.
Liao J, et al. Among authors: di vece d.
ESC Heart Fail. 2024 Nov 20. doi: 10.1002/ehf2.15136. Online ahead of print.
ESC Heart Fail. 2024.
PMID: 39564882
Free article.